Quality of life in patients with neovascular age-related macular degeneration before and after intravitreal therapy: a longitudinal observational study.
Аннотация
BACKGROUND
Age-related macular degeneration is a chronic and progressive disease that typically develops after the age of 50. Characterized by visual distortions, image blurring, and gradual central vision loss, age-related macular degeneration significantly impairs patients' ability to perform everyday activities and contributes to a marked reduction in quality of life. The gold standard treatment for the neovascular form of this condition consists of intravitreal injections. This therapy offers patients the possibility of improved vision-related quality of life by slowing disease progression and partially restoring visual function to levels approximating those prior to the onset of the condition. The aim of this study was to examine vision-related quality of life in individuals with neovascular age-related macular degeneration prior to treatment and following a course of seven intravitreal injections. The study also aimed to analyze its association with visual acuity, contrast sensitivity, and the occurrence and severity of metamorphopsia and central scotoma.
METHODS
This survey-based study was carried out using the author's questionnaire and a standardized research tool-the Polish version of National Eye Institute Visual Functioning Questionnaire. It also involved the analysis of the patients' medical records.
RESULTS
The study group consisted of 121 patients (121 eyes), comprising 60 women and 61 men, aged between 51 and 90 years. Following a course of intravitreal injections, a statistically significant improvement in vision-related quality of life, as measured by the Visual Functioning Questionnaire, was observed. The analysis also demonstrated an association between quality of life and visual function parameters.
CONCLUSION
Vision-related quality of life in patients with neovascular age-related macular degeneration was low at baseline and showed a modest improvement following initiation of intravitreal anti-VEGF therapy over the follow-up period. Across time points, better visual acuity, higher contrast sensitivity, and fewer visual disturbances on the Amsler grid were associated with higher vision-related quality of life scores. This study highlights the potential psychosocial benefits of intravitreal therapy in nAMD and may help support patients in initiating treatment or in maintaining adherence to continuing therapy.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.